Media Coverage header image

Media Coverage

Advanced Search
  • 07062023
    ROI-NJ

    Quest Diagnostics said Thursday that women seeking to start or expand a family can now access the Proov Confirm PdG home collection kit for assessing fertility through questhealth.com. The Proov Confirm PdG test is the first and only FDA-cleared PdG (progesterone metabolite) home test kit to confirm successful ovulation. Through a collaboration between Secaucus-based Quest and Proov, the test is the first women’s health test from a third-party manufacturer available through questhealth.com.

  • 06292023
    CNN

    For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. A study published Thursday in the CDC’s Morbidity and Mortality Weekly Report reveals how deep the disparities in access to hepatitis C therapies have become. Using testing data from Quest Diagnostics, researchers were able to track the fates of 1 million Americans diagnosed with hepatitis C infections in the decade since the most effective drugs were introduced. Overall, just 1 in 3 were cured over that time period.

  • 06222023
    NJBIZ

    Quest Diagnostics has finalized its previously announced acquisition of Baltimore-based Haystack Oncology, the Secaucus clinical laboratory company said June 21. Under the terms of the deal unveiled April 27, Quest said it would pay Haystack $300 million in cash at closing, net of cash acquired, and up to an additional $150 million based on future performance milestones.

  • 06142023
    SHRM HR News

    The ongoing flurry of marijuana legislation, court cases and cannabis-based products makes it difficult for HR professionals to craft policies that meet their company's drug-testing needs. The significant differences in state-by-state rules, definitions and interpretations of recreational and medical marijuana products have only added to the potential confusion. People in U.S. states that legalized recreational cannabis use it 20 percent more frequently than people in other states, according to a 2022 study in the journal Addiction. Nationwide, 4.4 percent of workers failed tests that Quest Diagnostics processed in 2020, up from 3.5 percent in 2012. The rate was slightly higher in states where adults are allowed to buy recreational marijuana.

  • 06082023
    Clinical Lab Products

    Alzheimer’s disease is devastating to both patients and their families and caregivers. And while there are better means to diagnosis Alzheimer’s today, in many cases, it is only determined after symptoms become apparent. Today, about 6 million Americans are struggling with Alzheimer’s disease and other dementias. That number is expected to more than double by mid-century. In a wide-ranging discussion about the disease with CLP, Michael Racke, MD, medical director of neurology for Quest Diagnostics, outlines a new test that can help spot Alzheimer’s and other dementias earlier, what that means for treatment options, and how it could help transform Alzheimer’s into a manageable condition and not a death sentence for patients.

  • 05292023
    The Pathologist

    Dr. Mark Kruzel, MD, MBA, Associate Medical Director of Oncology at Quest Diagnostics, shares how the pathology-oncology care team can work together more closely to leverage the true power of precision therapies.

  • 05182023
    CBS News

    As the number of cannabis-friendly states across the U.S. has grown, so, too, has the drug's usage among American workers. An annual analysis from Quest Diagnostics medical lab and testing company shows the percentage of general U.S. employees, who tested positive for cannabis in 2022 reached the highest level ever recorded by Quest, which began analyzing annual workplace drug testing data in 1988.

  • 05182023
    The Wall Street Journal

    As legal marijuana expands in the U.S., a record share of workers is testing positive for the substance in workplace drug screening. Overall drug use among workers tested by employers generally held steady last year, according to an annual tally from Quest Diagnostics, one of the country’s largest drug-testing laboratories. In drug tests given to workers after accidents on the job, marijuana positives rose sharply last year, hitting the highest level in a quarter-century.

  • 05122023
    Clinical Lab Products

    Quest Diagnostics announced nationwide availability of the RestoreU Dementia Panel, a risk assessment and care plan AI-powered test service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline.

  • 05112023
    USA Today

    Thursday marks the end of the public health emergency in the United States, more than three years after it was first declared to combat the novel coronavirus by unlocking powerful tools to detect and contain the emerging threat. While it closes a chapter in history, health experts point out the COVID-19 pandemic is not yet over as the virus continues to claim about 1,000 lives each week, according to the Centers for Disease Control and Prevention. Quest Diagnostics, one of the largest lab companies in the country, said labs will continue to provide COVID-19 services and tests, but “access to, fees and reimbursement for COVID-19 testing will change after the (public health emergency) expires.”

Show 5102550100 per page